Most PTCL-NOS and ALK-negative ALCLs derive little benefit, and PD-1-associated hyperprogression has been observed in ATLL and occasionally in other subtypes. Here, ALK is linked to mature T-cell and NK-cell non-Hodgkin lymphoma.